Neuromuscular blockers in myasthenia gravis and Lambert-Eaton

Поділитися
Вставка
  • Опубліковано 4 чер 2024
  • This is a review of how neuromuscular blocking agents (both depolarizing like succinylcholine and non-depolarizing like rocuronium) might behave in patients that have neuromuscular disorders, myasthenia gravis and Lambert-Eaton.
    Images adapted from Wikimedia Commons.
    ADDITIONAL TAGS:
    Neuromuscular blockers in myasthenia gravis and Lambert-Eaton
    Myasthenia gravis: Autoimmune loss of postsynaptic proteins (nicotinic AchR) of NMJ
    Generally avoid NMBA in MG, unless ndNMBA and sugammadex available
    MG has ↓ Ach receptors → resistant to depolarizing NMBAs
    2.6-fold ↑ in ED95 of succ
    Tx with anticholinesterase meds (-stigmines, donepezil, galantamine) may ↑ effects of succ
    MG: very sensitive to ndNMBA
    Administer ndNMBA in small doses (0.1*ED95) w ToF monitor
    Reverse with sugammadex; anticholinesterase reversal (neostigmine) can induce a cholinergic crisis
    Lambert-Eaton myasthenic syndrome: Autoimm destruction of presynaptic voltage-gated Ca_v → ↓ Ach release at NMJ
    Sensitive to both dNMBA and ndNMBA: Requires ↓ succ or roc
    Patients with LEMS are more sensitive to ndNMBAs than patients with MG
    Reversal with neostigmine might be ineffective
    Only use ndNMBAs if sugammadex is available: admin small titrated doses and monitor
    Condition sensitivity to:
    dNMBA (succ)
    ndNMBA (roc)
    MG:


    LEMS:


    If the goal is surgical paralysis …
    Amnt drug required in:
    dNMBA (succ)
    ndNMBA (roc)
    MG:


    LEMS:


    Normal neuromuscular junction:
    O = acetylcholine (ACh)
    Lambert-Eaton myasthenic syndrome: Autoimmune destruction of presynaptic voltage-gated Ca_v → ↓ Ach release at NMJ
    Myasthenia gravis: Autoimmune loss of postsynaptic nicotinic AchR of NMJ
    Depolarizing neuromuscular blocking agent (dNMBA = O) mimics acetylcholine, causing initial twitch then blocks further muscle action.
    Nondepolarizing neuromuscular blocking agent (ndNMBA = X) competes with acetylcholine for receptor sites, preventing muscle activation.
    Adapted from TrueLearn, Wikipedia, UpToDate. By Paul Hege - Own work, CC BY-SA 4.0, commons.wikimedia.org/w/index...

КОМЕНТАРІ •